{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T18:35:29Z","timestamp":1774722929379,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000679"],"award-info":[{"award-number":["32000679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072901"],"award-info":[{"award-number":["82072901"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\u03b2-site APP-cleaving enzyme 2 (BACE2) is a homolog of BACE1, which is considered as the most promising therapeutic target for Alzheimer\u2019s disease (AD). However, the expression and functional role of BACE2 in central nervous system (CNS) remain obscured. Previously, we identified several BACE2 rare variants in Hirschsprung disease (HSCR) patients and proved that BACE2-mediated APP cleavage might represent a novel HSCR pathogenesis mechanism in enteric nervous system. Here, we validated that these HSCR-associated BACE2 variants were loss-of-function mutations. Using the human pluripotent stem cell (hPSC)-derived brain organoids (BOs), we further demonstrated that BACE2 was mainly expressed in the ventricular zone and cortical plate of BOs, and its expression level was gradually increased along with the BO maturation. Functionally, we found that the BOs carrying the BACE2 loss-of-function mutation (<jats:italic>BACE2<\/jats:italic><jats:sup><jats:italic>G446R<\/jats:italic><\/jats:sup>) showed greater apoptosis and increased levels of A\u03b2 oligomers compared to the control BOs, resembling with the AD-associated phenotypes. All these phenotypes could be rescued via the removal of APP protein in <jats:italic>BACE2<\/jats:italic><jats:sup><jats:italic>G446R<\/jats:italic><\/jats:sup> BOs. Furthermore, rather than <jats:italic>BACE2<\/jats:italic><jats:sup><jats:italic>G446R<\/jats:italic><\/jats:sup>, <jats:italic>BACE2<\/jats:italic><jats:sup><jats:italic>WT<\/jats:italic><\/jats:sup> overexpression in BOs carrying the APP Swedish\/Indiana mutations attenuated the AD-associated phenotypes, including A\u03b2 accumulation and neuronal cell death. Taken together, our results unravel that BACE2 can protect the neuronal cell from apoptosis caused by A\u03b2 accumulation, and the deficiency of BACE2-mediated APP cleavage may represent a common pathological mechanism for both HSCR and AD.<\/jats:p>","DOI":"10.1038\/s41420-022-00845-5","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T16:06:04Z","timestamp":1643817964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids"],"prefix":"10.1038","volume":"8","author":[{"given":"Juan","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elly Sau-Wai","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7226-4214","authenticated-orcid":false,"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"845_CR1","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.jalz.2018.06.3059","volume":"14","author":"S Muller","year":"2018","unstructured":"Muller S, Preische O, Sohrabi HR, Graber S, Jucker M, Ringman JM, et al. Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2018;14:1427\u201337.","journal-title":"Alzheimer\u2019s Dement"},{"key":"845_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1471-4159.2009.06528.x","volume":"112","author":"RR Ahmed","year":"2010","unstructured":"Ahmed RR, Holler CJ, Webb RL, Li F, Beckett TL, Murphy MP. BACE1 and BACE2 enzymatic activities in Alzheimer\u2019s disease. J Neurochemistry. 2010;112:1045\u201353.","journal-title":"J Neurochemistry"},{"key":"845_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00726-007-0618-9","volume":"35","author":"MS Cheon","year":"2008","unstructured":"Cheon MS, Dierssen M, Kim SH, Lubec G. Protein expression of BACE1, BACE2 and APP in Down syndrome brains. Amino Acids. 2008;35:339\u201343.","journal-title":"Amino Acids"},{"key":"845_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","volume":"19","author":"DR Borchelt","year":"1997","unstructured":"Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 1997;19:939\u201345.","journal-title":"Neuron"},{"key":"845_CR5","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1111\/ejn.12235","volume":"37","author":"Y Deng","year":"2013","unstructured":"Deng Y, Wang Z, Wang R, Zhang X, Zhang S, Wu Y, et al. Amyloid-beta protein (Abeta) Glu11 is the major beta-secretase site of beta-site amyloid-beta precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Abeta Asp1 contributes to Alzheimer pathogenesis. Eur J Neurosci. 2013;37:1962\u20139.","journal-title":"Eur J Neurosci"},{"key":"845_CR6","doi-asserted-by":"publisher","first-page":"e50333.","DOI":"10.7554\/eLife.50333","volume":"8","author":"S Ghatak","year":"2019","unstructured":"Ghatak S, Dolatabadi N, Trudler D, Zhang X, Wu Y, Mohata M, et al. Mechanisms of hyperexcitability in Alzheimer\u2019s disease hiPSC-derived neurons and cerebral organoids vs isogenic controls. eLife. 2019;8:e50333.","journal-title":"eLife"},{"key":"845_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.20171831","volume":"215","author":"X Hu","year":"2018","unstructured":"Hu X, Das B, Hou H, He W, Yan R. BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions. J Exp Med. 2018;215:927\u201340.","journal-title":"J Exp Med"},{"key":"845_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.neurobiolaging.2007.01.002","volume":"29","author":"D Kobayashi","year":"2008","unstructured":"Kobayashi D, Zeller M, Cole T, Buttini M, McConlogue L, Sinha S, et al. BACE1 gene deletion: impact on behavioral function in a model of Alzheimer\u2019s disease. Neurobiol Aging. 2008;29:861\u201373.","journal-title":"Neurobiol Aging"},{"key":"845_CR9","doi-asserted-by":"publisher","first-page":"363ra150","DOI":"10.1126\/scitranslmed.aad9704","volume":"8","author":"ME Kennedy","year":"2016","unstructured":"Kennedy ME, Stamford AW, Chen X, Cox K, Cumming JN, Dockendorf MF, et al. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS beta-amyloid in animal models and in Alzheimer\u2019s disease patients. Sci Transl Med. 2016;8:363ra150.","journal-title":"Sci Transl Med"},{"key":"845_CR10","doi-asserted-by":"publisher","first-page":"30797","DOI":"10.1074\/jbc.M505249200","volume":"280","author":"D Dominguez","year":"2005","unstructured":"Dominguez D, Tournoy J, Hartmann D, Huth T, Cryns K, Deforce S, et al. Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. J Biol Chem. 2005;280:30797\u2013806.","journal-title":"J Biol Chem"},{"key":"845_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1042\/BST0350574","volume":"35","author":"JH Stockley","year":"2007","unstructured":"Stockley JH, O\u2019Neill C. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer\u2019s disease brain. Biochemical Soc Trans. 2007;35:574\u20136.","journal-title":"Biochemical Soc Trans"},{"key":"845_CR12","doi-asserted-by":"publisher","first-page":"20647","DOI":"10.1074\/jbc.M002688200","volume":"275","author":"BD Bennett","year":"2000","unstructured":"Bennett BD, Babu-Khan S, Loeloff R, Louis JC, Curran E, Citron M, et al. Expression analysis of BACE2 in brain and peripheral tissues. J Biol Chem. 2000;275:20647\u201351.","journal-title":"J Biol Chem"},{"key":"845_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1515\/hsz-2012-0104","volume":"393","author":"D Esterhazy","year":"2012","unstructured":"Esterhazy D, Akpinar P, Stoffel M. Tmem27 dimerization, deglycosylation, plasma membrane depletion, and the extracellular Phe-Phe motif are negative regulators of cleavage by Bace2. Biol Chem. 2012;393:473\u201384.","journal-title":"Biol Chem"},{"key":"845_CR14","doi-asserted-by":"publisher","first-page":"e98932","DOI":"10.1371\/journal.pone.0098932","volume":"9","author":"MP Rechsteiner","year":"2014","unstructured":"Rechsteiner MP, Floros X, Boehm BO, Marselli L, Marchetti P, Stoffel M, et al. Automated assessment of beta-cell area and density per islet and patient using TMEM27 and BACE2 immunofluorescence staining in human pancreatic beta-cells. PLoS ONE. 2014;9:e98932.","journal-title":"PLoS ONE"},{"key":"845_CR15","doi-asserted-by":"publisher","first-page":"10658","DOI":"10.1073\/pnas.1220748110","volume":"110","author":"L Rochin","year":"2013","unstructured":"Rochin L, Hurbain I, Serneels L, Fort C, Watt B, Leblanc P, et al. BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells. Proc. Natl Acad. Sci. USA. 2013;110:10658\u201363.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"845_CR16","doi-asserted-by":"publisher","first-page":"9712","DOI":"10.1073\/pnas.160115697","volume":"97","author":"M Farzan","year":"2000","unstructured":"Farzan M, Schnitzler CE, Vasilieva N, Leung D, Choe H. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc. Natl Acad. Sci. USA. 2000;97:9712\u20137.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"845_CR17","doi-asserted-by":"publisher","first-page":"34019","DOI":"10.1074\/jbc.M105583200","volume":"276","author":"R Yan","year":"2001","unstructured":"Yan R, Munzner JB, Shuck ME, Bienkowski MJ. BACE2 functions as an alternative alpha-secretase in cells. J Biol Chem. 2001;276:34019\u201327.","journal-title":"J Biol Chem"},{"key":"845_CR18","first-page":"269","volume":"6","author":"I Szymonska","year":"2015","unstructured":"Szymonska I, Borgenvik TL, Karlsvik TM, Halsen A, Malecki BK, Saetre SE, et al. Novel mutation-deletion in the PHOX2B gene of the patient diagnosed with Neuroblastoma, Hirschsprungas Disease, and Congenital Central Hypoventilation Syndrome (NB-HSCR-CCHS) Cluster. J Genet Syndr Gene Ther. 2015;6:269.","journal-title":"J Genet Syndr Gene Ther"},{"key":"845_CR19","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1053\/j.gastro.2018.09.012","volume":"155","author":"CS Tang","year":"2018","unstructured":"Tang CS, Li P, Lai FP, Fu AX, Lau ST, So MT, et al. Identification of genes associated with hirschsprung disease, based on whole-genome sequence analysis, and potential effects on enteric nervous system development. Gastroenterology. 2018;155:1908\u201322. e1905","journal-title":"Gastroenterology"},{"key":"845_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.gastro.2017.03.014","volume":"153","author":"FP Lai","year":"2017","unstructured":"Lai FP, Lau ST, Wong JK, Gui H, Wang RX, Zhou T, et al. Correction of hirschsprung-associated mutations in human induced pluripotent stem cells via clustered regularly interspaced short palindromic repeats\/Cas9, restores neural crest cell function. Gastroenterology. 2017;153:139\u201353. e138","journal-title":"Gastroenterology"},{"key":"845_CR21","first-page":"6674283","volume":"2021","author":"J Luo","year":"2021","unstructured":"Luo J, Zou H, Deng L, Sun X, Yuan P, Li P. Lin28 inhibits the differentiation from mouse embryonic stem cells to glial lineage cells through upregulation of Yap1. Stem Cells Int. 2021;2021:6674283.","journal-title":"Stem Cells Int"},{"key":"845_CR22","doi-asserted-by":"publisher","first-page":"102413","DOI":"10.1016\/j.scr.2021.102413","volume":"54","author":"J Luo","year":"2021","unstructured":"Luo J, Zou H, Li P. Src-Yap1 signaling axis controls the trophectoderm and epiblast lineage differentiation in mouse embryonic stem cells. Stem Cell Res. 2021;54:102413.","journal-title":"Stem Cell Res"},{"key":"845_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0304-3940(91)90738-F","volume":"129","author":"MC Chartier-Harlin","year":"1991","unstructured":"Chartier-Harlin MC, Crawford F, Hamandi K, Mullan M, Goate A, Hardy J, et al. Screening for the beta-amyloid precursor protein mutation (APP717: Val\u2014Ile) in extended pedigrees with early onset Alzheimer\u2019s disease. Neurosci Lett. 1991;129:134\u20135.","journal-title":"Neurosci Lett"},{"key":"845_CR24","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer\u2019s disease increases beta-protein production. Nature. 1992;360:672\u20134.","journal-title":"Nature"},{"key":"845_CR25","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.0403678101","volume":"101","author":"K Jin","year":"2004","unstructured":"Jin K, Galvan V, Xie L, Mao XO, Gorostiza OF, Bredesen DE, et al. Enhanced neurogenesis in Alzheimer\u2019s disease transgenic (PDGF-APPSw,Ind) mice. Proc. Natl Acad. Sci. USA. 2004;101:13363\u20137.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"845_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1006\/mcne.2000.0884","volume":"16","author":"I Hussain","year":"2000","unstructured":"Hussain I, Powell DJ, Howlett DR, Chapman GA, Gilmour L, Murdock PR, et al. ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site. Mol Cell Neurosci. 2000;16:609\u201319.","journal-title":"Mol Cell Neurosci"},{"key":"845_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000015608","volume":"89","author":"A Solans","year":"2000","unstructured":"Solans A, Estivill X, de La Luna S. A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer\u2019s amyloid precursor protein beta-secretase. Cytogenet Cell Genet. 2000;89:177\u201384.","journal-title":"Cytogenet Cell Genet"},{"key":"845_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajpath.2011.09.034","volume":"180","author":"CJ Holler","year":"2012","unstructured":"Holler CJ, Webb RL, Laux AL, Beckett TL, Niedowicz DM, Ahmed RR, et al. BACE2 expression increases in human neurodegenerative disease. Am J Pathol. 2012;180:337\u201350.","journal-title":"Am J Pathol"},{"key":"845_CR29","doi-asserted-by":"publisher","first-page":"e201800026","DOI":"10.26508\/lsa.201800026","volume":"1","author":"I Voytyuk","year":"2018","unstructured":"Voytyuk I, Mueller SA, Herber J, Snellinx A, Moechars D, van Loo G, et al. BACE2 distribution in major brain cell types and identification of novel substrates. Life Sci. Alliance. 2018;1:e201800026.","journal-title":"Life Sci. Alliance"},{"key":"845_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-7-46","volume":"7","author":"SO Abdul-Hay","year":"2012","unstructured":"Abdul-Hay SO, Sahara T, McBride M, Kang D, Leissring MA. Identification of BACE2 as an avid ss-amyloid-degrading protease. Mol. Neurodegener. 2012;7:46.","journal-title":"Mol. Neurodegener"},{"key":"845_CR31","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1038\/s41380-020-0806-5","volume":"6","author":"I Alic","year":"2021","unstructured":"Alic I, Goh PA, Murray A, Portelius E, Gkanatsiou E, Gough G, et al. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain. Mol Psychiatry. 2021;6:5766\u201388.","journal-title":"Mol Psychiatry"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00845-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00845-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00845-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:30:59Z","timestamp":1669303859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00845-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["845"],"URL":"https:\/\/doi.org\/10.1038\/s41420-022-00845-5","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}